Format

Send to

Choose Destination
Br J Cancer. 2007 Jul 2;97(1):1-5. Epub 2007 Jun 26.

Histone modifications as markers of cancer prognosis: a cellular view.

Author information

1
Department of Biological Chemistry, David Geffen School of Medicine, University of California, Los Angeles, CA 90095-1737, USA. skurdistani@mednet.ucla.edu

Abstract

Alterations in modifications of histones have been linked to deregulated expression of many genes with important roles in cancer development and progression. The effects of these alterations have so far been interpreted from a promoter-specific viewpoint, focussing on gene-gene differences in patterns of histone modifications. However, recent findings suggest that cancer tissues also display cell-cell differences in total amount of specific histone modifications. This novel cellular epigenetic heterogeneity is related to clinical outcome of cancer patients and may serve as a valuable marker of prognosis.

PMID:
17592497
PMCID:
PMC2359665
DOI:
10.1038/sj.bjc.6603844
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center